PSI
PCRX icon

Pinnacle Summer Investments’s Pacira BioSciences PCRX Stock Holding History

Pinnacle Summer Investments’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-110
Closed -$5K – 949
2015
Q3 		$5K Buy
+110
New +$6.74K ﹤0.01% 831
2015
Q2 		– Sell
-110
Closed -$10K – 894
2015
Q1 		$10K Buy
+110
New +$11.2K ﹤0.01% 788

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pinnacle Summer Investments's PCRX Position: Q4 2015 in Review

Pinnacle Summer Investments sold out of Pacira BioSciences (PCRX) in Q4 2015, closing a stake of 110 shares — an estimated $5K sold.

Pinnacle Summer Investments first reported a position in PCRX in Q1 2015 and held it in 2 quarters. The position peaked at $10K in Q1 2015. 214 funds tracked by Wall St. Rank hold PCRX as of Q4 2015.

  • Pinnacle Summer Investments reported no remaining Pacira BioSciences position as of Q4 2015 after selling out during the quarter.
  • Pinnacle Summer Investments sold 110 Pacira BioSciences shares in Q4 2015, an estimated $5K.
  • Pinnacle Summer Investments first reported a position in Pacira BioSciences in Q1 2015 and held it in 2 quarters.
  • Pinnacle Summer Investments's Pacira BioSciences position peaked at $10K in Q1 2015.
  • 214 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.